AdvanCell, une société radiopharmaceutique en phase clinique qui développe des traitements alpha ciblés anticancéreux innovants, a annoncé aujourd’hui la conception novatrice de la phase 2 de l’essai ...
La version audio de cet article est générée par la synthèse vocale, une technologie basée sur l’intelligence artificielle. À Victoria, BC Cancer mène un essai clinique unique en Colombie-Britannique d ...
The Defense Department has been aggressively pursuing laser weapons and defense systems, a push that gained significant attention this week when the use of an anti-drone laser system led to the ...
In fact, urinary-related symptoms are common — particularly as men age — and a majority of the time, they're not an indication of cancer. “The prostate naturally grows over time, which can narrow the ...
An enlarged prostate is a big problem for men, no pun intended. According to Yale Medicine, about 50% of men between the ages of 51 and 60 have benign prostatic hyperplasia (BPH) or an enlarged ...
Une véritable révolution technologique a pris place au centre Henri-Becquerel de Rouen. Le 29 janvier 2026, un premier patient atteint d’un cancer de la prostate s’est vu proposer un protocole de ...
Because treatment of the whole prostate can lead to long-term side effects in patients with prostate cancer, interest in minimally invasive, focal treatment options has been growing for certain ...
A novel cooled laser focal therapy device demonstrates 84% treatment success for localized prostate cancer at 3 months, with only 12% reporting erectile dysfunction and minimal impact on urinary ...
Because treatment of the whole prostate can lead to long-term side effects in patients with prostate cancer, interest in minimally invasive, focal treatment options has been growing for certain ...
L'hypertrophie de la prostate peut exercer une pression sur les voies urinaires, ce qui présente un risque de lésions rénales permanentes. La technologie de vapeur Rezum est une méthode minimalement ...
What Is Akeega, and Why Does It Matter? Akeega is a dual-action tablet combining two medicines — niraparib and abiraterone acetate — that has been approved by the FDA in combination with prednisone (a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results